Cary Street Partners Financial »

Inmune Bio Ord shares owned by Cary Street Partners Financial

Quarter-by-quarter ownership of Inmune Bio Ord (INMB) shares owned by Cary Street Partners Financial from 13F filings

Historical chart of Cary Street Partners Financial investment in Inmune Bio Ord

Tip: Access up to 7 years of quarterly data

All positions including Inmune Bio Ord held by Cary Street Partners Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inmune Bio Ord by Cary Street Partners Financial

Quarter filed Position value Share count Share price at filing
2025-12-31 $22k 14k 1.56
2025-09-30 $29k 14k 2.07

More positions owned by Cary Street Partners Financial

Apple Stock (AAPL)
Vanguard Value Etf Etf (VTV)
Vanguard Growth Etf Etf (VUG)
Microsoft Corp Stock (MSFT)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Fairlead Tactical Sector ETF Etf (TACK)
Tcw Flexible Income Etf Etf (FLXR)
Jpmorgan Equity Premium Income Etf Etf (JEPI)
Ishares Msci Eafe Growth Etf Etf (EFG)
Amazon Stock (AMZN)
Vanguard Small-cap Etf Etf (VB)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Jpmorgan Income Etf Etf (JPIE)
Ishares Msci Eafe Value Etf Etf (EFV)
Jpmorgan Active Growth Etf Etf (JGRO)

View all positions for Cary Street Partners Financial

Top funds holding Inmune Bio Ord

BlackRock
Vanguard Group
Geode Capital Management
Citadel Advisors
Susquehanna International
State Street Corporation
Dauntless Investment Group
Raymond James Financial
Northern Trust
Westside Investment Management
Wolverine Trading
XTX Topco
UBS Group
Bank of New York Mellon
Jpmorgan Chase & Co

View all funds holding Inmune Bio Ord